TLRY On A High, GALT Gallops, MLNT On Watch, ALRN To Report Phase II Data In Q4
The following are some of today's top gainers in the pharma/biotech sector.
More From BioPortfolio on "TLRY On A High, GALT Gallops, MLNT On Watch, ALRN To Report Phase II Data In Q4"